The National Cancer Center Research Institute in Tokyo reports that a newly isolated gut bacterium, designated ...

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

In eight tumors where patients failed immune checkpoint inhibitor (ICI) treatment, Plinabulin + radiation + PD-1 inhibitors demonstrated ...

It works by activating interleukin (IL)-2, an immune signaling molecule, and blocking CD80, a surface protein on immune cells, to enhance the cancer attack capability of immune cells. IL-2 plays a ...

The costimulatory molecule CD80 is an early marker for immune activation. It is upregulated on activated antigen-presenting cells. We aimed at developing a tracer for imaging CD80 by positron emission ...

The use of nanoparticles in vaccine formulations has become increasingly prevalent, with the rise of subunit vaccines. However, the production of nanoparticles is often not scalable, presenting a ...

TCM3 demonstrated selective T-cell transduction with no off-target effects and outperformed αCD3/CD80/CD58 (MDF) and αCD3/CD80 in efficiency when paired with different membrane fusion protein ...

TCM3 demonstrated selective T-cell transduction with no off-target effects and outperformed αCD3/CD80/CD58 (MDF) and αCD3/CD80 in efficiency when paired with different membrane fusion protein ...

By Dr. Liji Thomas, MD Accelerated lesion growth and key gut bacteria loss link the Western diet to heightened endometriosis ...

Discover Alpine Immune Sciences' groundbreaking patent for CD80-Fc fusion protein, offering new hope for immunological and oncological treatments. Explore the innovative amino acid substitutions and ...